Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Study of ATLCAR.CD138 Cells for Relapsed/Refractory Multiple Myeloma [Phase 1]
This clinical trial update reports a Phase 1 study of ATLCAR.CD138 cells for relapsed/refractory multiple myeloma, with the study listed as …
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: BCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma [Phase 1]
A Phase 1 trial of a BCMA-CD19 CAR-T cell therapy for relapsed/refractory multiple myeloma and plasmacytoid lymphoma is currently recruiting…
-
EMA approval · 2025-09-15EMA Authorised: Thalidomide Lipomed (thalidomide) — Lipomed GmbH
The European Medicines Agency authorised Thalidomide Lipomed (thalidomide) by Lipomed GmbH for use in multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Augmented Virtual Reality for Reducing Pain, Stress, Anxiety and Improve Self Efficacy in Adult Cancer Patients Undergoing Chemotherapy in The West Bank [NA]
This completed clinical trial evaluated augmented virtual reality as a nonpharmacologic approach to reduce pain, stress, and anxiety and to …
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Risk-adapted Therapeutic Strategy in +1q NDMM
Clinical trial update announcing a risk-adapted therapeutic strategy for newly diagnosed multiple myeloma with +1q abnormalities. The study …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration [Phase 3]
SWOG's Phase 3 trial S1803 is evaluating lenalidomide with or without daratumumab/rHuPH20 as post-autologous stem cell transplant maintenanc…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Integrated Actionable Aging Assessment for Cancer Patients Pilot [NA]
This entry summarizes a pilot trial from University of Colorado, Denver to develop an integrated aging assessment for cancer patients; the s…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
This clinical trial update describes a study assessing vaccine responses in patients who previously received CAR-T therapy for multiple myel…
-
CLINICAL_TRIALS other · 2025-09-15Clinical Trial Update: Evaluation of the Role of Connected Scales in the Therapeutic Care of Hematology Patients [NA]
This clinical trial update reports that the study sponsored by Assistance Publique - Hôpitaux de Paris is evaluating the use of connected sc…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Multi-center, Open-label, Phase 1b Study in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) [Phase 1]
Sanofi-sponsored multi-center open-label Phase 1b study in relapsed/refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma [Phase 1]
Sanofi completed a first-in-human Phase 1 trial of SAR442085 as a single-agent therapy for relapsed or refractory multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma [Phase 2]
Phase 2 trial comparing autologous stem cell transplantation with pomalidomide maintenance versus continuous clarithromycin/pomalidomide/dex…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide [Phase 2]
This Phase 2 trial evaluates health-related quality of life in people with multiple myeloma treated with daratumumab or lenalidomide. The st…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma [Phase 1, Phase 2]
terminated Phase 1/2 trial evaluating ide-cabtagene vicleucel (bb2121) combinations in multiple myeloma, reporting on safety and efficacy.
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating upfront treatment with elotuzumab, carfilzomib, lenalidomide, and dexamethasone in multiple myeloma has completed…
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: Repeated HBO Therapy in Myeloma Patients Undergoing High-Dose Therapy and Auto-HCT [EARLY_Phase 1]
An early-phase clinical trial update reports the completion of a study assessing repeated hyperbaric oxygen therapy in multiple myeloma pati…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Observational Study on the Combination of Selinexor With Bortezomib and Dexamethasone for the Treatment of MM Patients
An observational study is evaluating the combination of selinexor with bortezomib and dexamethasone for multiple myeloma and is currently re…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: 2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy [Phase 2]
A Phase 2 clinical trial update assessing early and late consolidation/maintenance therapy for multiple myeloma, with the study currently ac…
-
EMA approval · 2025-09-09EMA Authorised: Revlimid (lenalidomide) — Bristol-Myers Squibb Pharma EEIG
The European Medicines Agency authorised Revlimid (lenalidomide) for multiple indications including multiple myeloma, mantle cell lymphoma, …
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: An Open-label, Single-arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of OriV508 Injection in Treating Relapsed/Refractory Hematological Malignancies [EARLY_Phase 1]
This open-label, single-arm Phase 1 study is currently recruiting to evaluate the safety and preliminary efficacy of OriV508 injections in a…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: A Plant-Based Whole-Foods Meal Delivery Service for Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Cell Transplant [NA]
This is a completed clinical trial evaluating a plant-based whole-foods meal delivery service for patients with multiple myeloma undergoing …
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Evaluating Effectiveness of Powered Drill Bone Marrow Biopsy [NA]
A completed clinical trial from Emory University evaluating the effectiveness of a powered drill bone marrow biopsy in plasma cell myeloma (…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 3]
A Phase 3 trial evaluates bortezomib- or carfilzomib-based regimens with lenalidomide and dexamethasone in newly diagnosed multiple myeloma.
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating CC-92480 (BMS-986348) in combination with other treatments for relapsed or refractory multiple myeloma…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Pneumococcal Conjugated Vaccine 13 (PCV13) for Patients With Multiple Myeloma (MM) [Phase 4]
This document provides a Phase 4 clinical trial update on the Pneumococcal Conjugate Vaccine 13 (PCV13) for patients with multiple myeloma, …